Sonire Therapeutics

company

About

Sonire Therapeutics provides High-Intensity Focused Ultrasound treatment for cancer.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
¥530M
Industries
Biotechnology,Health Care,Health Diagnostics,Medical,Wellness
Founded date
Feb 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥530M
Sonire Therapeutics has raised a total of ¥530M in funding over 2 rounds. Their latest funding was raised on Jun 11, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 11, 2021 Series A ¥530M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Sonire Therapeutics is funded by 1 investors. Higin Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Higin Capital Series A